Scienture Holdings, Inc. Share Price
NASDAQ: SCNX | Micro CapScienture Holdings, Inc. Stock Performance
Open $0.38 | Prev. Close $0.38 | Circuit Range N/A |
Day Range $0.38 - $0.38 | Year Range $0.24 - $2.60 | Volume 282 |
Average Traded $0.38 |
Scienture Holdings, Inc. Share Price Today
As of 9 August 2026, Scienture Holdings, Inc.'s share price is $0.37. The stock opened at $0.38, compared to its previous close of $0.38. During today's trading session, Scienture Holdings, Inc.'s share price traded between $0.38 and $0.38, with an average price of $0.38. Over the past 52 weeks, the stock has recorded a high of $2.60 and a low of $0.24. In terms of performance, Scienture Holdings, Inc.'s share price has declined by 14.28% over the last six months and is down 62.29% on a year-on-year basis.
Scienture Holdings, Inc. Share Price Chart
Scienture Holdings, Inc. Stock Fundamentals & Key Indicators
Market Cap $5.68M | PE Ratio (TTM) -0.14 | Dividend Yield N/A |
EPS (TTM) $-2.70 | Revenue (TTM) $431609.00 | Return On Equity (TTM) -59.20% |
Profit Margin -9618.03% | Debt to Equity 0.04 | Quarterly Earnings Growth YoY -96.70% |
Scienture Holdings, Inc. Quarterly Profit & Loss
All figures in USD
Scienture Holdings, Inc. Annual Profit & Loss
All figures in USD
About Scienture Holdings, Inc.
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.
Scienture Holdings, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.38 | $0.38 | +2.96% |
Jul 2026 | $0.37 | $0.37 | +4.21% |
Jun 2026 | $0.38 | $0.36 | -14.01% |
May 2026 | $0.41 | $0.41 | +6.70% |
Apr 2026 | $0.26 | $0.39 | +37.59% |
Mar 2026 | $0.40 | $0.28 | -34.72% |
Feb 2026 | $0.44 | $0.43 | -4.64% |
Jan 2026 | $0.50 | $0.45 | -10.65% |
Dec 2025 | $0.59 | $0.51 | -14.79% |
Nov 2025 | $0.77 | $0.59 | -23.32% |
Oct 2025 | $0.85 | $0.78 | -7.40% |
Sep 2025 | $0.96 | $0.84 | -14.66% |
SCNX Share Price FAQs
What is Scienture Holdings, Inc. share price today?
What is the 52 week high and 52 week low of Scienture Holdings, Inc. stock?
What is SCNX's market capitalisation today?
What is SCNX's net income for the last quarter?
What is the 5 year returns of SCNX?
What is the high & low stock price of SCNX today?
Can I buy SCNX shares in India?